Isolation of vanconycin resistant Staphylococcus aureus from the wounds of hospital patients in Uyo, Akwa Ibom State, Nigeria

• Autorzy: Anosike I.K. , Ebana R.U.B. , Edet U.O. , Umoh I.S.
• Języki publikacji: EN

Abstrakty

EN

Staphylococcus aureus is a very important human pathogen that generates a number of human infections. Isolation of vancomycin-resistant Staphylococcus aureus (VRSA) was carried out from wound samples of patients attending University of Uyo Teaching Hospital, Akwa Ibom state, Nigeria. A total of 45 wound samples from 15 patients were collected aseptically in triplicate, using sterile cotton swabs moistened in sterile normal saline. Microbiological analysis and susceptibility to vancomycin, including minimum inhibitory and minimum bactericidal concentrations (MIC and MBC), were carried out using standard methodologies. A total of 15 isolates were obtained and these showed varying MIC and MBC patterns. Out of the 15 S. aureus isolated, only one isolate had an MIC of approximately 4 µg/ml, while twelve isolates gave MIC values that ranged from 15.62 µg/ml to 250 µg/ml. The remaining 2 isolates gave MIC values that were ≥ 500 µg/ml. These 2 isolates exhibited alpha haemolysis on blood agar, unlike the others that were beta haemolytic. The results of the MBC also showed variations amongst the isolates. A total of 10 isolates gave MBC values that ranged from 62.5 µg/ml to 500 µg/ml, while the remaining 5 isolates gave MBC values that were ≥ 500 µg/ml. The high MIC and MBC values obtained showed that vancomycin-resistant Staphylococcus aureus is increasing at an alarming rate, and this accounts for the gradual decline in the effectiveness associated with the use of vancomycin. Given the widespread prevalence of VRSA, there is a need for newer therapeutics that can reverse this surge.

• Wydawca: -
• Czasopismo: World News of Natural Sciences
• Rocznik: 2019
• Tom: 24
• Opis fizyczny: p.134-144,ref.

Twórcy

autor

Anosike I.K.

• Department of Microbiology, Faculty of Natural and Applied Sciences, Obong University, Obong Ntak, Etim Ekpo, Akwa Ibom State, Nigeria

autor

Ebana R.U.B.

• Department of Microbiology, Faculty of Natural and Applied Sciences, Obong University, Obong Ntak, Etim Ekpo, Akwa Ibom State, Nigeria

autor

Edet U.O.

• Department of Microbiology, Faculty of Natural and Applied Sciences, Obong University, Obong Ntak, Etim Ekpo, Akwa Ibom State, Nigeria

autor

Umoh I.S.

• Department of Microbiology, Faculty of Natural and Applied Sciences, Obong University, Obong Ntak, Etim Ekpo, Akwa Ibom State, Nigeria

Bibliografia

• [1] Saadat, S., Soljoo, K., Norooz-Nejad, M. J. & Kazemi, A. (2014). Van A and Van B Positive vancomycin-resistant Staphylococcus aureus among clinical Isolates in Shiraz, South of Iran. Oman Medical Journal, 29, 5335-5339
• [2] Trivedi, M B., Vegad, M. & Soni, S. (2015). Prevalence of methicillin-resistant Staphylococcus aureus in various clinical samples in a tertiary-care hospital. International journal of medical science and public health, 41(12), 1735-1738
• [3] Mboto, C. I., Edet, U. O., Mbim, E. N., Zenoh, D. A., Umego, C. F., Odidi, F. S., Tarh, S. A. & Upula, S. A. (2018). Human microbiome diversity: implications in health, disease, and applications. World News of Natural Sciences, 21, 98-117
• [4] Mbim, E. N., Mboto, C. I., Edet, U. O., Umego, C. F., George, U. E. & Temidayo, I. (2017). Comparative evaluation of methicillin-resistant Staphylococcus aureus (MRSA) isolates from hospital and community settings in Nigeria. Journal of Advances in Microbiology, 4(4), 1-9
• [5] Mbim, E. N, Mboto, C. I. & Edet, U. O. (2016). Prevalence and antimicrobial susceptibility profile of bacteria isolated from the environment of two major hospitals in Calabar metropolis, Nigeria. (2016). Journal of Advances in Medicine and Pharmaceutical Sciences, 10(4), 1-15
• [6] Mbim, E. N, Mboto, C. I. & Edet, U. O. (2016). Prevalence and antimicrobial susceptibility profile of bacteria isolated from the environment of two major hospitals in Calabar metropolis, Nigeria. Journal of Advances in Medicine and Pharmaceutical Sciences, 10(4), 1-15
• [7] Mbim, E. N., Mboto, C. I. & Edet, U. O. (2016). Plasmid profile analysis and curing of multidrug-resistant bacteria isolated from two hospital environments in Calabar metropolis, Nigeria. Asian Journal of Medicine and Health 1(1), 1-11
• [8] Popovich, K. J., Weinstein, R. A. & Hota, B. (2008). Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains. Clinical Infectious Diseases, 46, 787-794
• [9] Tiwari, R., Yadav, S. K. & Singh, S. (2016). Methicillin resistant Staphylococcus aureus isolated from wounds of livestock and companion animals of Uttar Pradesh India: A preliminary study. International Journal of Pharmacology, 12, 821-829
• [10] Limbago, B. M., Kallen, A. J., Zhu, W., Eggers, P., McDougal, L K., Albrecht, V. S. (2013). Report of the 13th Vancomycin-resistant Staphylococcus aureus isolate from the United States. Journal of Clinical Microbiology, 52(3), 998-1002
• [11] Azimian, A., Havael, S. A., Fazeli, H., Naderi, M., Ghazvini, K., Samiee, S. M. (2012). Genetic characterisation of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a University hospital in Northeastern Iran. Journal of Clinical Microbiology, 50(11), 3581-3585
• [12] Osman, A. S. (2016). Detection of vancomycin resistant-Staphylococcus aureus in clinical specimens in Khartoum (Sudan). African Journal of Medical Sciences, 2016, 1(6), 1-6
• [13] Chakraborty, S. P., Mahapatra, S. K., Bal, M. & Rpy, S. (2011). Isolation and identification of vancomycin resistant Staphylococcus aureus from post operative pus sample. Al Ameen Med Sci 4(2), 152-168
• [14] Otobo, U. N., Wala, P. G. & Agbagwa, O. E. (2018). Occurrence of vancomycin-resistant Staphylococcus aureus (VRSA) In clinical and community Isolates within the University of Port Harcourt. Advances in Biotechnology and Microbiology, 11(3), 001-004
• [15] Rana-Khara, R., Lakhani, S. J., Vasava, S., Shah, K. & Panjwani, D. (2016).Methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant Staphylococcus aureus (VRSA) from a rural based tertiary care and teaching hospital in Vadodara district, Gujarat. IAIM 3(7), 187-195
• [16] Alebachew, T., Yismaw, G., Derabe, A., Sisay, Z. (2012). Staphylococcus aureus burn wound infection among patients attending Yekatit 12 hospital burn unit, Addis Ababa, Ethiopia. Ethiopian Journal of Health Sciences, 22(3), 209-213
• [17] Ksherty, A. O., Pant, N. D., Bhandari, R., Khatri, S., Shrestha, L, K., Upadhaya, S. K., Poudel, A., Lekhak, B. & Raghubanshi, B. R. (2016). Minimum inhibitory concentration of vancomycin to methicillin resistant Staphylococcus aureus isolated from different clinical samples at a tertiary care hospital in Nepal. Antimicrobial Resistance and Infection Control, 5, 27
• [18] Shekarabi, M., Hajikhani, B., Chhirani, A. S., Fazell, M. & Goudarzi, M. (2017). Molecular characterization of vancomycin resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran. PLoS ONE, 12(8), e0183607
• [19] El Sayed, N., Ashour M. & Amine, A. E. K. (2018). Vancomycin resistance among Staphylococcus aureus isolates in a rural setting, Egypt. GERMS 8(3), 134-139
• [20] Almeida, G. C. M., dos Santos, M. M., Lima, N. G. M., Cidral, T. A., Melo, N. M. C. & Lima, K. C. (2014). Prevalence and factors associated with wound colonization by Staphylococcus spp and Staphylococcus aureus in hospitalized patients in inland northeastern Brazil: a cross-sectional study. BMC, 14, 328
• [21] Ebana, R. U. B., Edet, U. O., Anosike, I. K. & Etok, C. A. (2019). Bdellovibrio and like organisms: The much-anticipated “magic bullet”. World News of Natural Sciences 23 (2019) 233-249
• [22] Cheesebrough, M. (1998). District laboratory practice in tropical countries Cambridge. Cambridge University Press.
• [23] Barrow, G. I. & Feltham, R. K. A. (2003). In: Cowan and Steel’s Manual for the Identification of Medical Bacteria. First paperback edition. Published by the Press Syndicate of the University of Cambridge. The Pitt building, Trumpington street, Cambridge, United Kingdom.
• [24] Cruickshank, R., Duguid, J. P., Marnuim, B. P. & Surian, R. A. (1977). Medical Microbiology, 12th Edition, London Churchill-Livingstone.
• [25] Collins, C. H. Lyne, P. M. (1984). Microbiological methods 5th Edition. Butterwort and C. Publishing Ltd., London.
• [26] Holt et al (1995). Bergey’s manual of determinative bacteriology. 9th Edition, Maryland, Williams and Wilkins Baltimore, USA.
• [27] S. Manikandan, G. Thirunarayanan. Synthesis, spectral (FT-IR, ¹H and ¹³C NMR) and antimicrobial studies some of (E)-2-(2-((aryl)(phenyl)methylene)hydrazinyl)benzo[d] thiazole. World Scientific News 103 (2018) 1-18
• [28] Asmita V. Hirapara, Shipra H. Baluja. Synthesis, characterization and antimicrobial activity of pyrazolo chalcone compounds. World Scientific News 115 (2019) 242-259
• [29] Yadav, A., Sharma, A. & Deep, A. (2018). Vancomycin resistance in clinical isolates of methicillin resistant Staphylococcus aureus from a tertiary care hospital. Saudi Journal of pathology and microbiology, 3(10), 398-401
• [30] McDanel, J.S., Perencevich, E.N., Diekema D.J., Herwaldt L.A., Smith T.C., Chrischilles E.A., Dawson J.D., Jiang L., Goto M. & Schweizer M. L. (2015). Comparative effectiveness of beta-lactams varsusvancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals. Clinical Infectious Diseases, 61, 361-367
• [31] Sakoulas, G., Moise-Broder, P.A., Schentag, J., Forrest, A., Moellering, R. C. & Jr, Eliopoulos G.M. (2004). Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteraemia. Journal of Clinical Microbiology, 42, 2398-2402
• [32] Mavros M. N., Tansarli G. S., Vardakas K. Z., Rafailidis, P.L., Karageorgopoulos D. E.& Falagas M. E. (2012). Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. International Journal of Antimicrobial Agents, 40, 496-509
• [33] Honda H., Doern, C. D., Michael-Dunne W. Jr, & Warren, D. K. (2011). The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia. Bio Med Central Infectious Diseases. Doi:10.1186/1471-2334-11-335
• [34] Jacob J.T. & Diaz-Granados C.A. (2013). High vancomycin minimum inhibitory concentration and clinical outcomes in adult with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. International Journal of Infectious Diseases, 17(2), e93-e100